{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:34:16Z","timestamp":1776206056802,"version":"3.50.1"},"reference-count":46,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s546663","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:00:10Z","timestamp":1763964010000},"page":"10423-10435","source":"Crossref","is-referenced-by-count":1,"title":["Phase 1b Multicenter Study of SG001, a Humanized Anti-PD-1 Antibody, in Patients with Advanced Solid Tumors"],"prefix":"10.2147","volume":"Volume 19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3697-4563","authenticated-orcid":true,"given":"Jian","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-0534","authenticated-orcid":true,"given":"Ou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaqiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhendong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-811X","authenticated-orcid":true,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengquan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caicun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3958908","volume":"2019","author":"Darvin","year":"2019","journal-title":"J Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1158\/2159-8290.CD-16-1184","volume":"7","author":"Ajona","year":"2017","journal-title":"Cancer Discov"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/1751-2980.12538","volume":"18","author":"Wang","year":"2017","journal-title":"J Dig Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/21691401.2019.1573741","volume":"47","author":"Mu","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/cancers11030349","volume":"11","author":"Zhu","year":"2019","journal-title":"Cancers"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2008.03.056","volume":"268","author":"Loos","year":"2008","journal-title":"Cancer Lett"},{"key":"ref7","unstructured":"Administration FaD. Drugs@FDA: FDA-approved drugs 2015 Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=125527. Accessed November 12, 2025."},{"key":"ref8","unstructured":"Administration FaD. Drugs@FDA: FDA-approved drugs 2024 Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=BasicSearch.process. Accessed November 12, 2025."},{"key":"ref9","unstructured":"Administration FaD. Drugs@FDA: FDA-approved drugs 2017 Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=761078. Accessed November 12, 2025."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3529","volume":"362","author":"Shen","year":"2018","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/jamaoncol.2022.5816","volume":"9","author":"Yap","year":"2023","journal-title":"JAMA Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/cac2.12578","volume":"44","author":"Zuo","year":"2024","journal-title":"Cancer Commun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ygyno.2024.10.001","volume":"191","author":"Li","year":"2024","journal-title":"Gynecol Oncol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1177\/0091270009337512","volume":"49","author":"Wang","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"102254","DOI":"10.1016\/j.esmoop.2024.102254","volume":"9","author":"Lakhani","year":"2024","journal-title":"ESMO Open"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1158\/1078-0432.CCR-14-2607","volume":"21","author":"Patnaik","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00262-024-03660-2","volume":"73","author":"Yan","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/s41416-023-02431-7","volume":"129","author":"Day","year":"2023","journal-title":"Br J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1038\/s41416-022-02001-3","volume":"127","author":"Qin","year":"2022","journal-title":"Br J Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1200\/JCO.2021.39.15_suppl.2566","volume":"39","author":"Qin","year":"2021","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann Oncol"},{"key":"ref25","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology (NCCN Guidelines), non-small cell lung cancer, version 2 2024 Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf. Accessed November 12, 2025."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"key":"ref27","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae) mesothelioma: peritoneal version 3.2024 2024 Available from: https:\/\/bookcafe.yuntsg.com\/ueditor\/jsp\/upload\/file\/20241017\/1729130802212089594.pdf. Accessed November 12, 2025."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.6004\/jnccn.2024.0014","volume":"22","author":"Stevenson","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/jjco\/hyz104","volume":"49","author":"Nagata","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12885-021-08025-x","volume":"21","author":"Kitadai","year":"2021","journal-title":"BMC Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"21357","DOI":"10.1038\/s41598-021-00831-4","volume":"11","author":"Cedres","year":"2021","journal-title":"Sci Rep"},{"key":"ref32","unstructured":"Administration FaD. FDA approves nivolumab and ipilimumab for unresectable malignant pleural mesothelioma 2020 [Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-nivolumab-and-ipilimumab-unresectable-malignant-pleural-mesothelioma. Accessed November 12, 2025."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/S1470-2045(21)00471-X","volume":"22","author":"Fennell","year":"2021","journal-title":"Lancet Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e656","DOI":"10.3747\/co.27.6437","volume":"27","author":"Huang","year":"2020","journal-title":"Curr Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s41598-020-58674-4","volume":"10","author":"Sun","year":"2020","journal-title":"Sci Rep"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1001\/jamaoncol.2019.0393","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3389\/fphar.2017.00730","volume":"8","author":"Wang","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jtho.2018.07.007","volume":"13","author":"Fennell","year":"2018","journal-title":"J Thorac Oncol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imm.13141","volume":"159","author":"Fessas","year":"2020","journal-title":"Immunology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1200\/JCO.2014.58.3708","volume":"33","author":"Gettinger","year":"2015","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1200\/JCO.2016.68.1478","volume":"34","author":"Chow","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S1470-2045(16)00175-3","volume":"17","author":"Muro","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/109180","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/109180","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:00:13Z","timestamp":1763964013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/phase-1b-multicenter-study-of-sg001-a-humanized-anti-pd-1-antibody-in--peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":46,"URL":"https:\/\/doi.org\/10.2147\/dddt.s546663","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}